Author

Carlo Pozzilli

Institution: Sapienza University of Rome

Observed institution: Sapienza University of Rome

OpenAlex ID: A5159713613

Efficacy and safety of ocrelizumab in primary progressive multiple sclerosis, including older patients and those with more advanced disease (ORATORIO-HAND): a multicentre, double-blind, randomised, placebo-controlled, phase 3b study

2026 · Gavin Giovannoni, Laura Airas, et al. · The Lancet · 11

Uncovering disability progression in people with multiple sclerosis: a practical guide

2026 · Bart Van Wijmeersch, Celia Oreja-Guevara, et al. · Journal of Neurology

Works count: 2

Citation count: 11

H-index: 1

I10-index: 1